Thyroid Function, Reverse Triiodothyronine, and Mortality in Critically Ill Clinical Patients.

IF 1.5
Carlos Dg da Silveira, Flávio Pj de Vasconcelos, Edmilson B Moura, Bruno Tg da Silveira, Flávio Fp Amorim, Lumie S Shintaku, Rosália B de Santana, Pedro Lp Argotte, Sheila F da Silva, Marcelo de Oliveira Maia, Fabio F Amorim
{"title":"Thyroid Function, Reverse Triiodothyronine, and Mortality in Critically Ill Clinical Patients.","authors":"Carlos Dg da Silveira,&nbsp;Flávio Pj de Vasconcelos,&nbsp;Edmilson B Moura,&nbsp;Bruno Tg da Silveira,&nbsp;Flávio Fp Amorim,&nbsp;Lumie S Shintaku,&nbsp;Rosália B de Santana,&nbsp;Pedro Lp Argotte,&nbsp;Sheila F da Silva,&nbsp;Marcelo de Oliveira Maia,&nbsp;Fabio F Amorim","doi":"10.5005/jp-journals-10071-24001","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>To evaluate the association of thyroid hormones changes, including increased reverse triiodothyronine (rT3) level, with critically ill clinical patients´ mortality.</p><p><strong>Patients and methods: </strong>This study analyzed the observational data prospectively collected over 8 months (2018) in an adult intensive care unit (ICU) in Brasilia, Brazil. All consecutive ICU-admitted clinical patients were included. Thyroxine (T4), free thyroxine (fT4), triiodothyronine (T3), free triiodothyronine (fT3), rT3, and thyroid-stimulating hormone (TSH) were collected within 48 hours of ICU admission. Patients with hypothyroidism or hyperthyroidism who were previously diagnosed were excluded.</p><p><strong>Results: </strong>Of 353 included patients, age was 68.5 ± 19.0 years, sequential organ failure assessment (SOFA) score was 3.3 ± 2.9, and Acute Physiology and Chronic Health Evaluation II (APACHE II) was 17.1 ± 7.9. ICU mortality was 17.6% (<i>n</i> = 62). Non-survivor patients had a higher incidence of increased rT3 (69.3 vs 59.2%, <i>p</i> = 0.042), lower incidence of low T4 (4.8 vs 9.7%, <i>p</i> = 0.045), and increased age (75.2 ± 16.3 years vs 67.1 ± 19.3 years, <i>p</i> = 0.001), SOFA (3.0 ± 0.4 vs 2.8 ± 2.6, <i>p</i> <0.001), and APACHE II (23.5 ± 7.5 vs 15.7 ± 7.2, <i>p</i> <0.001). Alterations in other thyroid hormones did not show association with mortality. Increased rT3 [odds ratio (OR): 2.436; 95% confidence interval (CI): 1.023-5.800; <i>p</i> = 0.020] and APACHE II (OR: 1.083, 95% CI: 1.012-1.158; <i>p</i> = 0.044) were associated with ICU mortality in the multivariate analysis.</p><p><strong>Conclusion: </strong>Increased rT3 was independently associated with increased ICU mortality. In contrast, other thyroid hormone alterations did not show an association with mortality. Determining rT3 levels may be a helpful test to identify an increased risk for ICU mortality in clinical patients.</p><p><strong>How to cite this article: </strong>da Silveira CDG, de Vasconcelos FPJ, Moura EB, da Silveira BTG, Amorim FFP, Shintaku LS, <i>et al.</i> Thyroid Function, Reverse Triiodothyronine, and Mortality in Critically Ill Clinical Patients. Indian J Crit Care Med 2021;25(10):1161-1166.</p>","PeriodicalId":520643,"journal":{"name":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","volume":" ","pages":"1161-1166"},"PeriodicalIF":1.5000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/97/ef/ijccm-25-1161.PMC8645806.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10071-24001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Background: To evaluate the association of thyroid hormones changes, including increased reverse triiodothyronine (rT3) level, with critically ill clinical patients´ mortality.

Patients and methods: This study analyzed the observational data prospectively collected over 8 months (2018) in an adult intensive care unit (ICU) in Brasilia, Brazil. All consecutive ICU-admitted clinical patients were included. Thyroxine (T4), free thyroxine (fT4), triiodothyronine (T3), free triiodothyronine (fT3), rT3, and thyroid-stimulating hormone (TSH) were collected within 48 hours of ICU admission. Patients with hypothyroidism or hyperthyroidism who were previously diagnosed were excluded.

Results: Of 353 included patients, age was 68.5 ± 19.0 years, sequential organ failure assessment (SOFA) score was 3.3 ± 2.9, and Acute Physiology and Chronic Health Evaluation II (APACHE II) was 17.1 ± 7.9. ICU mortality was 17.6% (n = 62). Non-survivor patients had a higher incidence of increased rT3 (69.3 vs 59.2%, p = 0.042), lower incidence of low T4 (4.8 vs 9.7%, p = 0.045), and increased age (75.2 ± 16.3 years vs 67.1 ± 19.3 years, p = 0.001), SOFA (3.0 ± 0.4 vs 2.8 ± 2.6, p <0.001), and APACHE II (23.5 ± 7.5 vs 15.7 ± 7.2, p <0.001). Alterations in other thyroid hormones did not show association with mortality. Increased rT3 [odds ratio (OR): 2.436; 95% confidence interval (CI): 1.023-5.800; p = 0.020] and APACHE II (OR: 1.083, 95% CI: 1.012-1.158; p = 0.044) were associated with ICU mortality in the multivariate analysis.

Conclusion: Increased rT3 was independently associated with increased ICU mortality. In contrast, other thyroid hormone alterations did not show an association with mortality. Determining rT3 levels may be a helpful test to identify an increased risk for ICU mortality in clinical patients.

How to cite this article: da Silveira CDG, de Vasconcelos FPJ, Moura EB, da Silveira BTG, Amorim FFP, Shintaku LS, et al. Thyroid Function, Reverse Triiodothyronine, and Mortality in Critically Ill Clinical Patients. Indian J Crit Care Med 2021;25(10):1161-1166.

甲状腺功能、逆转三碘甲状腺原氨酸与危重症患者死亡率。
背景:评估甲状腺激素变化,包括逆转三碘甲状腺原氨酸(rT3)水平升高与危重症临床患者死亡率的关系。患者和方法:本研究分析了巴西巴西利亚成人重症监护病房(ICU) 8个月(2018年)的前瞻性观察数据。纳入所有连续icu住院的临床患者。入院48小时内采集甲状腺素(T4)、游离甲状腺素(fT4)、三碘甲状腺原氨酸(T3)、游离三碘甲状腺原氨酸(fT3)、rT3、促甲状腺激素(TSH)。排除既往诊断为甲状腺功能减退或甲状腺功能亢进的患者。结果:353例患者的年龄为68.5±19.0岁,顺序器官衰竭评分(SOFA)为3.3±2.9分,急性生理和慢性健康评估II (APACHE II)为17.1±7.9分。ICU死亡率为17.6% (n = 62)。非存活患者的rT3升高发生率较高(69.3 vs 59.2%, p = 0.042),低T4发生率较低(4.8 vs 9.7%, p = 0.045),年龄增加(75.2±16.3岁vs 67.1±19.3岁,p = 0.001), SOFA(3.0±0.4 vs 2.8±2.6,p = 0.020)和APACHE II (OR: 1.083, 95% CI: 1.012-1.158;p = 0.044)与ICU死亡率相关。结论:rT3升高与ICU死亡率升高独立相关。相比之下,其他甲状腺激素的改变与死亡率没有关联。测定rT3水平可能有助于鉴别临床患者ICU死亡风险的增加。如何引用本文:da Silveira CDG, de Vasconcelos FPJ, Moura EB, da Silveira BTG, Amorim FFP, Shintaku LS等。甲状腺功能、逆转三碘甲状腺原氨酸与危重症患者死亡率。中华检验医学杂志;2009;25(10):1161-1166。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书